Organizational Facilitators and Barriers to Medication for Opioid Use Disorder Capacity Expansion and Use

Nora Jacobson, Julie Horst, Liam Wilcox-Warren, Alex Toy, Hannah K. Knudsen, Randy Brown, Eric Haram, Lynn Madden, Todd Molfenter

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Medication for opioid use disorder (MOUD) is a key strategy for addressing the opioid use disorder crisis, yet gaps in MOUD provision impede this strategy’s benefits. The research reported here sought to understand what distinguishes low- and high-performing organizations in building and using capacity to provide MOUD. As part of a mixed methods MOUD implementation trial, semi-structured telephone interviews were conducted with personnel from low- and high-performing MOUD-providing organizations. Seventeen individuals from 17 organizations were interviewed. Findings demonstrate the importance of individual, organization, and community-level factors in supporting the building and use of MOUD capacity. Low- and high-performing organizations showed different patterns of facilitators and barriers during the implementation process. The key difference between low- and high-performing organizations was the level of organizational functioning. A better understanding of an organization’s assets and deficits at the individual, organizational, and community levels would allow decision-makers to tailor their approaches to MOUD implementation.

Original languageEnglish
Pages (from-to)439-448
Number of pages10
JournalJournal of Behavioral Health Services and Research
Volume47
Issue number4
DOIs
StatePublished - Oct 1 2020

Bibliographical note

Funding Information:
This study was supported by a grant from the National Institute on Drug Abuse (NIDA Grant R01DA030431; PI: Molfenter). Acknowledgments

Publisher Copyright:
© 2020, National Council for Behavioral Health.

ASJC Scopus subject areas

  • Health(social science)
  • Health Policy
  • Public Health, Environmental and Occupational Health

Fingerprint

Dive into the research topics of 'Organizational Facilitators and Barriers to Medication for Opioid Use Disorder Capacity Expansion and Use'. Together they form a unique fingerprint.

Cite this